Almirall (FRA:E2Z) ROE % Adjusted to Book Value : 1.75% (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Almirall ROE % Adjusted to Book Value?

Almirall's ROE % for the quarter that ended in Mar. 2024 was 2.01%. Almirall's PB Ratio for the quarter that ended in Mar. 2024 was 1.15. Almirall's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 1.75%.

Almirall ROE % Adjusted to Book Value Historical Data

The historical data trend for Almirall's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall ROE % Adjusted to Book Value Chart

Almirall Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

4.14

3.83

-2.03

0.27

-2.31

Almirall Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	2.01	1.17	-	1.75

Competitive Comparison of Almirall's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Almirall's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Almirall's ROE % Adjusted to Book Value falls into.

Almirall ROE % Adjusted to Book Value Calculation

Almirall's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-2.77%	/	1.20
	=	-2.31%

Almirall's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.01%	/	1.15
	=	1.75%

Almirall ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Almirall's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Almirall (FRA:E2Z) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (FRA:E2Z) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

LBTSF:USA 0O9B:UK ALM:Spain E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall (FRA:E2Z) Headlines

No Headlines